Yes, Mounjaro (tirzepatide) can cause temporary hair shedding. The UK Mounjaro SmPC lists it as a common adverse reaction, reported in 4.9% of people on tirzepatide versus 1.0% on placebo across the pooled SURMOUNT-1, -2 and -3 weight-management trials — and it is far more common in women (about 7% versus under 1% of men on the US data). But the usual cause isn't the drug attacking your follicles — it's telogen effluvium, a stress-and-nutrition response to rapid weight loss and low protein intake. Shedding usually starts around 3 months after the trigger and settles within 3 to 6 months once weight loss plateaus, with visible volume returning over about 6 to 9 months. Hitting a daily protein floor (~1.2-1.6 g/kg) is the main lever you actually control.

Does Mounjaro cause hair loss? What the evidence actually says

Hair shedding is a real but uncommon Mounjaro side effect. The regulators put numbers on it. Pooling the tirzepatide obesity trials, the US Zepbound label reports hair loss in 5%, 4% and 5% of people on the 5 mg, 10 mg and 15 mg doses against 1% on placebo; the UK Mounjaro SmPC, pooling SURMOUNT-1, -2 and -3, gives 4.9% versus 1.0%. The averages hide a large sex difference — the US label breaks it down as 7.1% of women versus 0.5% of men, against 1.3% and 0% on placebo. It was almost always mild, and no one taking Zepbound in those trials stopped treatment because of it.

Here's the part most pages skate over: the loss is driven by the weight loss, not by tirzepatide poisoning the follicle. The FDA prescribing information for tirzepatide describes the hair-loss reports as associated with weight reduction. That distinction matters, because it means the shedding is usually self-limiting and the fix is largely in your hands.

The UK label nuance: Mounjaro vs Zepbound

This one genuinely confuses UK readers, so let's clear it up — starting with the part most articles get wrong. There is no Zepbound in the UK. Zepbound is the US brand name for tirzepatide licensed for weight management. In the UK, tirzepatide is sold as Mounjaro for both indications — type 2 diabetes and weight management — under a single Summary of Product Characteristics. So if you have read that "hair loss is on the Zepbound label but not the Mounjaro one," that framing is imported from the US and does not describe anything you can look up here.

What the UK Mounjaro SmPC actually says is more useful. Hair loss is listed as an adverse reaction, at common frequency, footnoted specifically to the weight-management trials. The SmPC reports that across the pooled SURMOUNT-1, -2 and -3 weight-management studies, hair loss occurred in 4.9% of people on tirzepatide versus 1.0% on placebo.

The two-brands split is real, but it is a US phenomenon. On the US labels, Zepbound (weight management) lists Hair Loss in its clinical-trial adverse-reactions table — 5%, 4% and 5% on the 5 mg, 10 mg and 15 mg doses against 1% on placebo, pooled across its two obesity studies. US Mounjaro (type 2 diabetes) does not list it in any trial table at all; alopecia appears only under Postmarketing Experience, which means spontaneous reports with no reliable frequency attached.

The practical read is the same in both countries: hair shedding is a recognised, documented effect that clusters in the weight-management setting, and the labels themselves tie it to weight reduction rather than to the molecule doing something to your follicles directly. An omission on one leaflet reflects which trials that licence was built on — not proof the effect cannot happen to you. Raise hair changes with your prescriber either way.

Telogen effluvium: the real reason your hair sheds on Mounjaro

At any moment, most of your hair is growing and a small share is resting before it falls out and gets replaced. Telogen effluvium is what happens when a shock — rapid weight loss, a physiological stressor, or a nutrient gap — pushes an unusually large batch of follicles into that resting phase at once. A couple of months later, that whole batch sheds together. You notice more hair in the shower drain or the brush, and often a diffuse thinning across the scalp rather than bald patches.

Two things about GLP-1 weight loss make this more likely. First, losing weight quickly is itself a metabolic stressor. Second, when appetite drops sharply, protein and micronutrient intake often fall right alongside calories — and hair is one of the first non-essential tissues your body deprioritises when building blocks are scarce. The American Academy of Dermatology and the British Association of Dermatologists both describe telogen effluvium as a common, reversible form of shedding frequently linked to rapid weight loss, crash dieting, and nutritional deficiency.

The reassuring part: in telogen effluvium the follicle isn't damaged or scarred. It's paused, not destroyed. That's why the story almost always ends with regrowth — and why the useful question isn't "how do I stop the drug," but "am I feeding my hair enough while I eat less?"

The protein connection nobody tracks (the actual lever)

Every ranking page tells you to "eat more protein." Almost none of them turn that into a number you can hit — which is exactly where people fall short.

Here's the trap. On Mounjaro, appetite suppression can pull your intake down to something like 1,200-1,500 kcal a day without much effort or hunger. That's often the point. But protein doesn't shrink politely alongside everything else — you have to aim for it, and a suppressed appetite makes that harder precisely when your hair (and your muscle) needs it most. Under-eating protein is the nutrient-shortfall mechanism the pharmacy pages name but never operationalise.

So make it a floor, not a vibe. During active weight loss the commonly used target is roughly 1.2-1.6 g of protein per kg of body weight per day, well above the ~0.75-0.8 g/kg general adult baseline. If you are also doing resistance training, the International Society of Sports Nutrition's position stand puts the range for building and maintaining muscle higher still, at 1.4-2.0 g/kg/day. A worked example: a 75 kg person is looking at about 90-120 g of protein a day. Landing 20-40 g per meal is a practical way to get there and supports muscle-protein synthesis at each sitting.

Track it, don't guess it. Tiro shows your protein-floor progress every day — set to ~1.2-1.6 g/kg for your own weight — with a running per-meal bar, so you can see whether you're actually clearing the floor while eating less. Calories stay in the background; protein is the number that protects your hair and your muscle. Track your daily protein floor →

It's not just protein

Protein is the biggest lever, but telogen effluvium is sensitive to other deficiencies too — iron, zinc, and vitamin D are the usual suspects flagged in dermatology guidance on diffuse shedding. This is a blood-test-and-prescriber conversation, not a reason to raid the supplement aisle. Over-supplementing some nutrients (iron especially) carries its own risks. If shedding is significant, ask your GP whether checking ferritin, thyroid, and vitamin D makes sense for you.

The same lever on semaglutide

If you're on Wegovy or Ozempic rather than Mounjaro, none of this changes. Semaglutide drives weight loss and appetite suppression through the same GLP-1 pathway, so semaglutide protein requirements are effectively identical — the same 1.2-1.6 g/kg floor, the same telogen-effluvium risk when you under-eat it. If you want the meal-by-meal breakdown, see how many grams of protein per meal on Ozempic.

How long does Mounjaro hair loss last — and will it grow back?

Telogen effluvium follows a recognisable sequence, though "predictable" oversells it — in roughly a third of cases no trigger is ever identified at all.

The shed usually starts about 3 months after the trigger, with a reported range of 1 to 6 months. On a titration schedule that often lands right around the weeks you were losing weight fastest. It then continues for a few months, peaks, and settles.

Here is the part that catches GLP-1 users out, and almost no page mentions it. The classic model assumes a single one-off shock — an illness, a surgery, a crash diet — after which the clock starts running. Losing weight steadily for a year on tirzepatide is not one shock; it is a trigger that keeps repeating. So the recovery clock realistically starts when your weight plateaus, not when you started the drug. If you are four months in, still losing fast, and waiting for the shedding to stop on schedule, the schedule has not started yet.

Once weight does stabilise, shedding generally settles within about 3 to 6 months. Getting your hair to look normal again takes longer — usually 6 to 9 months for density to return, and considerably longer for length, because hair grows only about a centimetre a month. A year to look like yourself again is normal and is not a sign something has gone wrong.

One honest caveat: because telogen effluvium thins hair diffusely, it sometimes reveals an androgenetic (pattern) hair loss that was already developing underneath. If density does not recover after the shedding stops, that is worth a GP or dermatologist appointment rather than more protein.

Will it grow back? For the great majority, yes. Because the follicle isn't damaged in telogen effluvium, hair typically returns to its previous density once the underlying trigger — rapid loss, protein shortfall — is corrected. New regrowth can look shorter or wispier at first; that's the follicle waking up, not failing.

The catch worth knowing is the timing lag. Because the shed trails the trigger by months, it's genuinely hard to connect "why is my hair falling out now" to "the eight weeks I barely ate protein back in the spring" from memory alone.

See the pattern, not just the panic. Log the day your shedding started and Tiro lines it up against your injection weeks and dose steps — so you and your prescriber can see, for example, that it began about ten weeks after your fastest weight-loss stretch. See it against your dose timeline →

Shedding after stopping Mounjaro

Coming off Mounjaro brings its own adjustments — appetite returns, weight can drift back, and any renewed swing in your body's equilibrium can nudge the telogen cycle again. It's usually a smaller story than the initial rapid-loss shed, but if you're planning to pause or stop, it's worth reading when food noise comes back after stopping so the changes don't blindside you.

What actually helps (and when to see your prescriber)

Ranked by how much leverage you actually have:

Hit the protein floor every day. This is the one you control outright. Clearing ~1.2-1.6 g/kg consistently is the single most useful thing you can do for shedding tied to under-eating.
Don't lose faster than you need to. If loss is very rapid, the pace is a titration and clinician conversation — titration is the main tolerability lever on these drugs, and your prescriber decides it, not a blog. Never change your dose on your own.
Cover hydration and micronutrients. Stay hydrated, eat a varied diet, and let a blood test — not guesswork — guide any iron/zinc/vitamin-D questions with your GP.
Be gentle with the hair you have. Telogen effluvium sheds hair that was already destined to go; harsh styling won't cause it, but easy handling avoids adding breakage on top.

One under-appreciated link: nausea is the most common GI side effect on GLP-1s and usually eases once you settle on a stable dose. But while it's bad, people often eat almost nothing — deepening the exact protein shortfall that feeds hair loss. Managing GI symptoms well indirectly protects your hair.

Log it and get "is this normal?" pointers. Record hair shedding like any other side effect in Tiro and get non-prescriptive, dermatology-informed prompts on what to raise with your prescriber. Log this side effect →

See a GP or dermatologist — don't just wait it out — if the loss is patchy rather than diffuse, lasts beyond about six months, comes with scalp symptoms (redness, itching, pain), or is severe. Those features point away from simple telogen effluvium toward causes like iron-deficiency anaemia, thyroid problems, or other conditions that need their own workup. Wondering whether it's fat or muscle you're actually losing? That's a body-composition question too — watch non-scale progress instead of the scale.

Bottom line

Mounjaro-related hair loss is uncommon, temporary, and reversible for almost everyone. It's telogen effluvium — a shedding response to rapid weight loss and the protein shortfall that appetite suppression makes easy to fall into — not the drug destroying your follicles. The lever you own is your daily protein floor: ~1.2-1.6 g/kg, cleared consistently, tracked rather than guessed, and read against your own dose timeline. If shedding is patchy, prolonged, or worrying, see your prescriber or a dermatologist. And remember the disclaimer above — this is information, not medical advice.

Mounjaro progress isn't just the scale. Track your protein floor, log symptoms against your dose, and watch body-composition change in one companion. Get the Tiro GLP-1 companion app →

Frequently asked questions

Does Mounjaro cause hair loss? It can, though it's uncommon. The UK Mounjaro SmPC reports hair loss in 4.9% of people on tirzepatide versus 1.0% on placebo, pooled across the SURMOUNT-1, -2 and -3 weight-management trials. The US Zepbound label shows the same picture by dose (5%, 4% and 5% versus 1% on placebo) and notes it is strongly skewed toward women. The usual cause is telogen effluvium — temporary shedding from rapid weight loss and low protein or nutrient intake — not a direct effect of the drug on the follicle.

How much protein should I eat on Mounjaro to protect my hair? Aim for a daily protein floor of about 1.2-1.6 g per kg of body weight during active weight loss — roughly 90-120 g for a 75 kg person, ideally split into 20-40 g per meal. Confirm the right target for you with your prescriber or a registered dietitian.

How long does Mounjaro hair loss last? Shedding typically begins about 3 months after the trigger (reported range 1 to 6 months) and settles within about 3 to 6 months once the trigger stops. For GLP-1 users the key point is that the clock starts when weight loss plateaus, not when you started the drug — ongoing rapid loss keeps re-triggering it. Visible volume returns over roughly 6 to 9 months after that.

Will my hair grow back after Mounjaro? For most people, yes. Telogen effluvium doesn't damage the follicle, so hair typically regrows once the trigger settles. Loss that is patchy or lasts beyond about six months should be checked by a GP or dermatologist.

Is hair loss listed as a Mounjaro side effect in the UK? Yes — and the premise of that question is worth correcting, because there is no Zepbound in the UK. Tirzepatide is licensed here as Mounjaro for both type 2 diabetes and weight management, under one SmPC, and that SmPC lists hair loss as a common adverse reaction at 4.9% versus 1.0% on placebo across the pooled weight-management trials. The "on one label but not the other" split you may have read about describes the US, where Zepbound and Mounjaro are separate products. Discuss any hair changes with your prescriber.

Does hair loss happen on Wegovy and Ozempic too? Yes. Semaglutide (Wegovy, Ozempic) works through the same GLP-1 pathway, so the same rapid-loss-plus-low-protein route to telogen effluvium applies.

Sources

Mounjaro (tirzepatide) Summary of Product Characteristics — electronic Medicines Compendium, revised 9 April 2026. §4.8 lists hair loss as a common adverse reaction, 4.9% vs 1.0% on placebo across pooled SURMOUNT-1, -2 and -3.
Zepbound (tirzepatide) US Prescribing Information — DailyMed, revised 4/2026. §6.1 Table 2 hair-loss rates by dose; narrative on the 7.1% female / 0.5% male split and the association with weight reduction.
Mounjaro (tirzepatide) US Prescribing Information — DailyMed, revised 4/2026. Alopecia appears only under §6.2 Postmarketing Experience, with no frequency attached.
Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205–216 — the SURMOUNT-1 trial.
Wegovy (semaglutide) US Prescribing Information — DailyMed, revised June 2026. §6.1 reports hair loss in 3.3% on 2.4 mg vs 1.0% on placebo, rising to 5.8% at 7.2 mg.
Hughes EC, Syed HA, Saleh D. Telogen Effluvium. StatPearls, updated 1 May 2024 — onset latency, the acute/chronic threshold, and why regrowth lags the end of shedding.
Telogen effluvium — British Association of Dermatologists patient information leaflet, October 2025.
Jäger R, et al. International Society of Sports Nutrition Position Stand: protein and exercise. Journal of the International Society of Sports Nutrition. 2017;14:20 — 20–40 g per serving, and 1.4–2.0 g/kg/day for exercising individuals.
Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity Pillars. 2025;15:100181 — the 1.2–1.6 g/kg proposal during active weight reduction.

Mounjaro and Hair Loss: The Protein Connection Nobody Tracks (And How to Fix It)